Bone marrow-derived mesenchymal stem cells attenuate pulmonary inflammation and lung damage caused by highly pathogenic avian influenza A/H5N1 virus in BALB/c mice
Autor: | Rima R. Prasetya, Yasuko Mori, Kazufumi Shimizu, Gatot Soegiarto, Yohko K. Shimizu, Soetjipto Koesnowidagdo, Fedik Abdul Rantam, Laksmi Wulandari, Maria Inge Lusida, Jezzy R. Dewantari, Aldise Mareta Nastri, Emmanuel Djoko Poetranto, Muhammad Amin, Resti Yudhawati |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine Arterial blood gas analysis BALB/c mouse 030106 microbiology Lung injury Mesenchymal Stem Cell Transplantation Bone marrow-derived mesenchymal stem cells Virus lcsh:Infectious and parasitic diseases BALB/c Mice 03 medical and health sciences Orthomyxoviridae Infections Highly pathogenic avian influenza a/H5N1 virus Acute lung injury Animals Cell-based therapy Medicine lcsh:RC109-216 Lung Alveolar Cell Type I Mice Inbred BALB C Alveolar cell regeneration Influenza A Virus H5N1 Subtype Acute respiratory distress syndrome biology business.industry Mesenchymal stem cell Alveolar Cell Type II Pneumonia respiratory system Inflammatory cytokines biology.organism_classification respiratory tract diseases Disease Models Animal Treatment Outcome 030104 developmental biology Infectious Diseases medicine.anatomical_structure Immunology Cytokines Bone marrow business Research Article |
Zdroj: | BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-15 (2020) BMC Infectious Diseases |
ISSN: | 1471-2334 |
Popis: | Background The highly pathogenic avian influenza A/H5N1 virus is one of the causative agents of acute lung injury (ALI) with high mortality rate. Studies on therapeutic administration of bone marrow-derived mesenchymal stem cells (MSCs) in ALI caused by the viral infection have been limited in number and have shown conflicting results. The aim of the present investigation is to evaluate the therapeutic potential of MSC administration in A/H5N1-caused ALI, using a mouse model. Methods MSCs were prepared from the bone marrow of 9 to 12 week-old BALB/c mice. An H5N1 virus of A/turkey/East Java/Av154/2013 was intranasally inoculated into BALB/c mice. On days 2, 4, and 6 after virus inoculation, MSCs were intravenously administered into the mice. To evaluate effects of the treatment, we examined for lung alveolar protein as an indicator for lung injury, PaO2/FiO2 ratio for lung functioning, and lung histopathology. Expressions of NF-κB, RAGE (transmembrane receptor for damage associated molecular patterns), TNFα, IL-1β, Sftpc (alveolar cell type II marker), and Aqp5+ (alveolar cell type I marker) were examined by immunohistochemistry. In addition, body weight, virus growth in lung and brain, and duration of survival were measured. Results The administration of MSCs lowered the level of lung damage in the virus-infected mice, as shown by measuring lung alveolar protein, PaO2/FiO2 ratio, and histopathological score. In the MSC-treated group, the expressions of NF-κB, RAGE, TNFα, and IL-1β were significantly suppressed in comparison with a mock-treated group, while those of Sftpc and Aqp5+ were enhanced. Body weight, virus growth, and survival period were not significantly different between the groups. Conclusion The administration of MSCs prevented further lung injury and inflammation, and enhanced alveolar cell type II and I regeneration, while it did not significantly affect viral proliferation and mouse morbidity and mortality. The results suggested that MSC administration was a promissing strategy for treatment of acute lung injuries caused by the highly pathogenic avian influenza A/H5N1 virus, although further optimization and combination use of anti-viral drugs will be obviously required to achieve the goal of reducing mortality. |
Databáze: | OpenAIRE |
Externí odkaz: |